Listed

Turning Point Brands, Inc.: Form 10-Q for the period ended Sep 30, 2017

Filed with the SEC on Nov 9, 2017 and accepted by EDGAR at Nov 9, 2017, 16:15 ET.

Share

Management's discussion and analysis

As filed, 51,389 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should read the following discussion of the historical financial condition and results of operations in conjunction with our interim condensed consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q, with our annual consolidated financial statements and accompanying notes, which are included in our 2016 Annual Report on Form 10-K. In addition, this discussion includes forward-looking statements subject to risks and uncertainties which may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors” in our 2016 Annual Report on Form 10-K, those included in this Quarterly Report on Form 10-Q, and other reports filed with the Securities and Exchange Commission from time to time.

The following discussion relates to the interim, unaudited financial statements of the Company included elsewhere in this Quarterly Report on Form 10-Q. In this discussion, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and our consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. Dollars are in thousands, except where designated and in per share data. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.

Overview

We are a leading, independent provider of Other Tobacco Products (“OTP”) in the U.S. We sell a wide range of products across the OTP spectrum including moist snuff tobacco (“MST”), loose leaf chewing tobacco, premium cigarette papers, make-your-own (“MYO”) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. We do not sell cigarettes. We estimate the OTP industry generated approximately $10.5 billion in manufacturer revenue in 2016. In contrast to manufactured cigarettes, which have been experiencing declining sales for decades based on data published by the Alcohol and Tobacco Tax and Trade Bureau (“TTB”) the OTP industry is demonstrating increased consumer appeal with low to mid-single digit consumer unit growth as reported by Management Science Associates, Inc. (“MSAi”), a third-party analytics and informatics company.

The Company’s reportable segments are (1) smokeless products, which include chewing tobacco and MST, (2) smoking products, which principally include cigarette papers, MYO cigar wraps, and cigars, and (3) NewGen products, which include liquid vapor products, tobacco vaporizer products and non-nicotine/non-tobacco products.

Our portfolio of brands includes some of the most widely recognized names in the OTP industry such as Zig-Zag®, Beech-Nut®, Stoker’s®, and VaporBeast™.

Our core tobacco business generates revenues from the sale of our products primarily to wholesale distributors who, in turn, resell them to retail operations, as well as from the sale of our products directly to retail operations. Additionally, the acquisition of VaporBeast allows us to sell directly to non-traditional retail operations. Our net sales, which include federal excise taxes and FDA fees, consist of gross sales, net of cash discounts, returns, and selling and marketing allowances.

Our principal operating expenses include the cost of raw materials, used to produce the limited number of products we manufacture; the cost of finished products, which are purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. Our other principal expenses include interest expense and amortization of deferred financing costs and other expenses.

Recent Developments

On November 9, 2017, our Board of Directors approved the initiation of a cash dividend to shareholders. The initial quarterly dividend of $0.04 per common share will be paid on December 15, 2017 to shareholders of record at the close of business on November 27, 2017.

On July 28, 2017, the U.S. Food and Drug Administration (“FDA”) announced a new direction in regulating tobacco products, including the newly “deemed” markets such as cigars and vapor products. FDA stated it intends to begin several new rulemaking processes, some of which will outline foundational rules governing the premarket application process for the deemed products, including Substantial Equivalence Applications and Premarket Tobacco Applications. Compliance and related costs could be significant and could increase the costs of operating in our NewGen Segment. The original filing deadlines for the applications of these newly “deemed” products on the market as of August 8, 2016, have been postponed until August 8, 2021, for “combustible” products (e.g., cigar and pipe) and August 8, 2022, for “non-combustible” products (e.g., vapor products). No other application filing deadlines were altered. FDA also acknowledged a “continuum of risk” among tobacco products (i.e., that certain tobacco products pose a greater risk to individual and public health than others), that it intends to seek public comment on the role that flavors play in attracting youth and the role that flavors may play in helping some smokers switch to potentially less harmful forms of nicotine delivery, and that it will increase its focus on the regulation of cigarette products.

On June 30, 2017, we filed a Form S-3 Registration Statement with the Securities and Exchange Commission providing for the potential to offer up to $200 million in the aggregate of our common stock, preferred stock, depository shares, warrants, and units, as well as a secondary offering and sale of up to approximately 12.8 million shares of TPB common stock by selling shareholders. We currently have no plans to utilize the offering; however, we believe it provides future flexibility as we continue to drive our strategic organic growth and acquisition initiatives.

In March 2017, we entered into a strategic partnership with the Hand Media, Inc., dba Vapor Shark (“Vapor Shark”), a leading distributor and manufacturer of premium vaping e-liquids and hardware with nationwide distribution through independent retail vape shops as well as Vapor Shark retail locations. Through the strategic partnership, we were issued a warrant to purchase all outstanding stock of Vapor Shark in exchange for a commitment to deposit up to $2.5 million. In April 2017, we entered into a management agreement with Vapor Shark whereby we gained control of the Vapor Shark operations. On June 30, 2017, we exercised the warrant and obtained ownership of 100% of the outstanding shares of Vapor Shark. Our exercise of the warrant triggered an option giving Vapor Shark’s former sole shareholder the right to purchase Vapor Shark’s company-owned stores for $1. The former sole shareholder has notified us of his intent to exercise this option no earlier than January 1, 2018.

In November 2016, we purchased all of the capital stock of Smoke Free Technologies, Inc., d/b/a VaporBeast (“VaporBeast”), for an aggregate purchase price of approximately $27 million. VaporBeast is a leading distributor of liquid vapor products servicing the non-traditional retail channel. Also in November 2016, we purchased five regional smokeless tobacco brands from Wind River Tobacco Company (“Wind River”) for a purchase price of approximately $2.5 million.

In May 2016, we sold 6,210,000 shares of voting common stock in our IPO (including shares sold pursuant to an underwriters’ option to purchase 810,000 shares to cover over-allotments) at a price of $10.00 per share. The gross proceeds of the IPO totaled $62.1 million. Refer to the 2016 Annual Report on Form 10-K for use of the IPO proceeds.

In April 2016, we increased the total authorized shares of preferred and voting and non-voting common stock and effected a 10.43174381 for 1 stock split of our voting and non-voting common stock. As a result of the stock split, all previously reported share amounts (including options and warrants) in the accompanying financial statements and related notes of the Company have been retrospectively restated to reflect the stock split.

Segment Information

We operate in three reportable segments: (1) smokeless products, (2) smoking products, and (3) NewGen products. The smokeless products segment (a) manufactures and markets moist snuff and (b) contracts for and markets chewing tobacco products. The smoking products segment (a) imports and markets cigarette papers, tubes, and related products and (b) imports and markets finished cigars and MYO cigar wraps. The NewGen products segment (a) markets e-cigarettes, e-liquids, vaporizers and other related products and (b) distributes a wide assortment of vaping products to non-traditional retail outlets.

Key Factors Affecting Our Results of Operations

We consider the following factors to be the key factors affecting our results of operations:

  • Our ability to further penetrate markets with our existing products;
  • Our ability to introduce new products and product lines that complement our core business;
  • Decreasing interest in tobacco products among consumers;
  • Price sensitivity in our end-markets;
  • Marketing and promotional initiatives, which cause variability in our results;
  • General economic conditions, including consumer access to disposable income;
  • Cost, and increasing regulation, of promotional and advertising activities;
  • Cost of complying with regulation;
  • Counterfeit and other illegal products in our end-markets;
  • Currency fluctuations;
  • Our ability to identify attractive acquisition opportunities in OTP; and
  • Our ability to integrate acquisitions.

Critical Accounting Policies and Uses of Estimates

There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K.

Recent Accounting Pronouncements Adopted:

We adopted Accounting Standard Update (“ASU”) 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment in Q1 of 2017. This ASU simplifies the measurement of goodwill by eliminating Step 2 from the goodwill impairment test. The adoption of the ASU had no effect on our consolidated financial statements.

We adopted ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory in Q1 of 2017. The amendments in this ASU require entities that measure inventory using the first-in, first-out or average cost methods to measure inventory at the lower of cost and net realizable value. Net realizable value is defined as estimated selling price in the ordinary course of business less reasonably predictable costs of completion, disposal, and transportation. The adoption of this ASU had no effect on our consolidated financial statements.

Recent Accounting Pronouncements:

In May 2014, the Financial Accounting Standards Board (the “FASB”) issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), requiring an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The updated standard will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either a full retrospective, or retrospective with cumulative effect, transition method. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606), which delayed the effective date of ASU 2014-09 by one year. ASU 2014-09 is now effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting year. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods within that reporting period. The standard may be applied retrospectively to each prior period presented, or retrospectively with the cumulative effect recognized, as of the date of adoption ("modified retrospective method"). We currently expect to apply the modified retrospective method upon adoption. We do not believe the standard will impact our recognition of revenue as we are primarily a distributor of goods; however, we continue to assess the potential impacts to other less significant revenue transactions.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes Topic 840, Leases. ASU 2016-02 requires a lessee to recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less for which there is not an option to purchase the underlying asset that the lessee is reasonably certain to exercise, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities and should recognize lease expense for such leases, generally on a straight-line basis over the lease term. Certain qualitative disclosures along with specific quantitative disclosures will be required for users to understand more about the nature of an entity’s leasing activities. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with early adoption permitted. At transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach, which includes a number of optional practical expedients related to the identification and classification of leases commenced before the effective date of ASU 2016-02. An entity electing to use the practical expedients will, in effect, continue to account for leases commenced before the effective date in accordance with previous GAAP unless the lease is modified, except that lessees are required to recognize a right-of-use asset and a lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental payments tracked and disclosed under previous GAAP. We are currently evaluating the effect the adoption of this standard will have on our financial statements.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The amendments in this ASU require a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. ASU 2016-18 is effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, on a retrospective basis. We are currently evaluating the effect the adoption of this standard will have on our financial statements.

In March 2017, the FASB issued ASU 2017-07, Compensation-Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. This ASU requires an employer to disaggregate the service cost component from the other components of net benefit cost. This ASU also allows only the service cost component of net benefit cost to be eligible for capitalization. ASU 2017-07 is effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. We are currently evaluating the effect the adoption of this standard will have on our financial statements.

Results of Operations

Summary

The table and discussion set forth below relate to our consolidated results of operations:

Consolidated Results of Operations Data: Net sales Three Months Ended September 30, 2017 2016 % Change
Smokeless products $21,294 $18,909 12.6%
Smoking products 26,860 28,760 -6.6%
NewGen products 25,186 3,290 665.5%
Total net sales 73,340 50,959 43.9%
Cost of sales 40,410 26,341 53.4%
Gross profit
Smokeless products 11,478 9,396 22.2%
Smoking products 14,201 14,411 -1.5%
NewGen products 7,251 811 794.1%
Total gross profit 32,930 24,618 33.8%
Selling, general and administrative expenses 18,554 12,727 45.8%
Operating income 14,376 11,891 20.9%
Interest expense 4,023 5,557 -27.6%
Investment income (131) (279) -53.0%
Income before income taxes 10,484 6,613 58.5%
Income tax expense (benefit) 3,110 (180) -1827.8%
Consolidated net income $7,374 $6,793 8.6%

Comparison of the Three Months Ended September 30, 2017, to the Three Months Ended September 30, 2016

Net Sales. For the three months ended September 30, 2017, overall net sales increased to $73.3 million from $51.0 million for the three months ended September 30, 2016, an increase of $22.3 million or 43.9%. For the quarter, volumes increased 39.5% and price/mix increased 4.4%. This increase was primarily a result of increased net sales in our NewGen segment.

Effective July 1, 2017, the tax on all OTP products sold in California increased to 65.1%. Implementation of the tax has led to decreases in 2017 California OTP volume when compared to volume over the same 2016 period.

For the three months ended September 30, 2017, net sales in the Smokeless products segment increased to $21.3 million from $18.9 million for the three months ended September 30, 2016, an increase of $2.4 million or 12.6%. For the quarter, volume increased 8.2% and price/mix increased 4.4%. Net sales growth was primarily driven by Stoker’s MST.

Pennsylvania implemented a $0.55 per ounce excise tax on smokeless products effective October 1, 2016. Implementation of the tax has led to decreases in 2017 Pennsylvania volume when compared to volume over the same 2016 period.

Year-over-year industry volumes for chewing tobacco declined by approximately 10% in the quarter while MST was down approximately 2% according to MSAi. The Company outpaced the industry in the quarter and grew its MSAi share in both chewing tobacco and MST on the strength of Stoker’s volumes.

For the three months ended September 30, 2017, net sales in the Smoking products segment decreased to $26.9 million from $28.8 million for the three months ended September 30, 2016, a decrease of $1.9 million or 6.6%. For the quarter, Smoking products volumes decreased 9.3% while price/mix increased 2.7%. The decrease was the result of a strong year ago comparison due to the timing of Zig-Zag MYO cigar wraps promotional purchases, continued weakness in cigars, the California tax on OTP products including MYO cigar wraps, and one fewer shipping day, partially offset by year-over-year strength in Zig-Zag cigarette papers.

Industry volumes for cigarette papers increased by mid-single-digits while MYO cigar wraps grew by double-digits, according to MSAi. Zig-Zag maintained its industry-leading share position in both premium cigarette papers and MYO cigar wraps, according to MSAi.

For the three months ended September 30, 2017, net sales in the NewGen products segment increased to $25.2 million from $3.3 million for the three months ended September 30, 2016, an increase of $21.9 million or 665.5%. For the quarter, NewGen products volumes increased 645.6%, while price/mix increased 19.9%. Net sales growth was primarily driven by the inclusion of VaporBeast and Vapor Shark for the quarter.

Gross Profit. For the three months ended September 30, 2017, overall gross profit increased to $32.9 million from $24.6 million for the three months ended September 30, 2016, an increase of $8.3 million or 33.8%, primarily due to the inclusion of VaporBeast’s and Vapor Shark’s gross profit in 2017. As a result of the inclusion of the VaporBeast business, gross margin decreased to 44.9% for the three months ended September 30, 2017, from 48.3% for the three months ended September 30, 2016.

For the three months ended September 30, 2017, gross profit in the Smokeless products segment increased to $11.5 million from $9.4 million for the three months ended September 30, 2016, an increase of $2.1 million or 22.2%. Gross profit as a percentage of net sales increased to 53.9% of net sales for the three months ended September 30, 2017, from 49.7% of net sales for the three months ended September 30, 2016, due to mix, lower product return rates, product price increases, and a favorable LIFO charge.

For the three months ended September 30, 2017, gross profit in the Smoking products segment decreased to $14.2 million from $14.4 million for the three months ended September 30, 2016, a decrease of $0.2 million or 1.5%. Gross profit as a percentage of net sales increased to 52.9% of net sales for the three months ended September 30, 2017, from 50.1% of net sales for the three months ended September 30, 2016, due to product mix.

For the three months ended September 30, 2017, gross profit in the NewGen products segment increased to $7.3 million from $0.8 million for the three months ended September 30, 2016, an increase of $6.4 million or 794.1%, primarily as a result of the inclusion of VaporBeast in 2017. Gross profit as a percentage of net sales increased to 28.8% of net sales for the three months ended September 30, 2017, from 24.7% of net sales for the three months ended September 30, 2016.

Selling, General and Administrative Expenses. For the three months ended September 30, 2017, selling, general and administrative expenses increased to $18.6 million from $12.7 million for the three months ended September 30, 2016, an increase of $5.8 million or 45.8%, due primarily to the inclusion of SG&A from VaporBeast in the three months ended September 30, 2017, strategic acquisition expenses, and sales and marketing infrastructure investments.

Interest Expense. For the three months ended September 30, 2017, interest expense decreased to $4.0 million from $5.6 million for the three months ended September 30, 2016, primarily as a result of our February 2017 debt refinancing.

Income Tax Expense (Benefit). The Company’s income tax expense of $3.1 million for the three months ended September 30, 2017, is lower than expected based on our estimated annual effective tax rate as a result of discrete tax benefits of $0.9 million from the exercise of stock options during the quarter. The Company’s income tax benefit for the three months ended September 30, 2016, does not bear the normal relationship to income before income taxes because of net operating loss carryforwards which were utilized and were partially offset by certain minimum state income taxes.

Investment Income. For the three months ended September 30, 2017 and 2016, investment income relating to investments of the MSA escrow deposits was $0.1 million and $0.3 million, respectively.

Consolidated Net Income. Due to the factors described above, net income for the three months ended September 30, 2017 and 2016, was $7.4 million and $6.8 million, respectively.

Consolidated Results of Operations Data: Net sales Nine Months Ended September 30, 2017 2016 % Change
Smokeless products $63,563 $58,939 7.8%
Smoking products 81,056 83,434 -2.9%
NewGen products 67,595 10,033 573.7%
Total net sales 212,214 152,406 39.2%
Cost of sales 119,623 78,267 52.8%
Gross profit
Smokeless products 32,270 29,498 9.4%
Smoking products 42,018 42,390 -0.9%
NewGen products 18,303 2,251 713.1%
Total gross profit 92,591 74,139 24.9%
Selling, general and administrative expenses 53,823 40,563 32.7%
Operating income 38,768 33,576 15.5%
Interest expense 13,002 20,895 -37.8%
Investment income (334) (611) -45.3%
Loss on extinguishment of debt 6,116 2,824 116.6%
Income before income taxes 19,984 10,468 90.9%
Income tax expense 3,850 642 499.7%
Consolidated net income 16,134 9,826 64.2%
Net loss attributable to non-controlling interest (556) -
Net income attributable to Turning Point Brands, Inc. $16,690 $9,826

Comparison of the Nine Months Ended September 30, 2017, to the Nine Months Ended September 30, 2016

Net Sales. For the nine months ended September 30, 2017, overall net sales increased to $212.2 million from $152.4 million for the nine months ended September 30, 2016, an increase of $59.8 million or 39.2%. For the nine months ended September 30, 2017, volumes increased 35.2% and price/mix increased 4.0%. This increase was primarily a result of increases in the Smokeless products and the NewGen products segments.

Effective July 1, 2017, the tax on all OTP products sold in California increased to 65.1%. Implementation of the tax has led to decreases in 2017 California volume when compared to volume over the same 2016 period.

For the nine months ended September 30, 2017, net sales in the Smokeless products segment increased to $63.6 million from $58.9 million for the nine months ended September 30, 2016, an increase of $4.6 million or 7.8%. For the nine months, volume increased 3.6% and price/mix increased 4.2%. Net sales growth was primarily driven by Stoker’s MST.

Pennsylvania implemented a $0.55 per ounce excise tax on smokeless products effective October 1, 2016. Implementation of the tax has led to decreases in 2017 Pennsylvania volume when compared to volume over the same 2016 period.

Year-over-year industry volumes for chewing tobacco declined by approximately 10% in the nine months while MST volumes decreased by 1%, according to MSAi. The Company’s volume performance outpaced the industry in the nine months and grew its MSAi share in both chewing tobacco and MST.

For the nine months ended September 30, 2017, net sales in the Smoking products segment decreased to $81.1 million from $83.4 million for the nine months ended September 30, 2016, a decrease of $2.4 million or 2.9%. For the nine months ended September 30, 2017, Smoking products’ volumes decreased 5.2%, while price/mix increased 2.3%.

Industry volumes for cigarette papers declined by 1% while MYO cigar wraps grew by 15%, according to MSAi. Zig-Zag increased its market share versus the year-ago period in cigarette papers and held an 80% share in MYO cigar wraps, according to MSAi.

For the nine months ended September 30, 2017, net sales in the NewGen products segment increased to $67.6 million from $10.0 million for the nine months ended September 30, 2016, an increase of $57.6 million or 573.7%. For the nine months ended September 30, 2017, NewGen products volumes increased 556.2%, while price/mix increased 17.5%. Net sales growth was primarily driven by the inclusion of VaporBeast in the nine-month period and Vapor Shark in the second and third quarters of 2017.

Gross Profit. For the nine months ended September 30, 2017, overall gross profit increased to $92.6 million from $74.1 million for the nine months ended September 30, 2016, an increase of $18.5 million or 24.9%, primarily due to the inclusion of nine months of VaporBeast results. Gross margin weakened to 43.6% for the nine months ended September 30, 2017, from 48.6% for the nine months ended September 30, 2016, as a result of the mix impact of VaporBeast’s inherently lower distribution margins.

For the nine months ended September 30, 2017, gross profit in the Smokeless products segment increased to $32.3 million from $29.5 million for the nine months ended September 30, 2016, an increase of $2.7 million or 9.4%. Gross profit as a percentage of net sales increased to 50.8% of net sales for the nine months ended September 30, 2017, from 50.0% of net sales for the nine months ended September 30, 2016.

For the nine months ended September 30, 2017, gross profit in the Smoking products segment decreased to $42.0 million from $42.4 million for the nine months ended September 30, 2016, a decrease of $0.4 million or 0.9%. Gross profit as a percentage of net sales increased to 51.8% of net sales for the nine months ended September 30, 2017, from 50.8% of net sales for the nine months ended September 30, 2016.

For the nine months ended September 30, 2017, gross profit in the NewGen products segment increased to $18.3 million from $2.3 million for the nine months ended September 30, 2016, an increase of $16.1 million or 713.1%. Gross profit as a percentage of net sales increased to 27.1% of net sales for the nine months ended September 30, 2017, from 22.4% of net sales for the nine months ended September 30, 2016.

Selling, General and Administrative Expenses. For the nine months ended September 30, 2017, selling, general and administrative expenses increased to $53.8 million from $40.6 million for the nine months ended September 30, 2016, an increase of $13.3 million or 32.7%, due primarily to the inclusion of nine months of VaporBeast’s SG&A.

Interest Expense. For the nine months ended September 30, 2017, interest expense decreased to $13.0 million from $20.9 million for the nine months ended September 30, 2016, primarily as a result of our 2017 debt refinancing.

Income Tax Expense. The Company’s income tax expense of $3.9 million for the nine months ended September 30, 2017, is lower than expected based on our estimated annual effective tax rate as a result of discrete tax benefits of $4.5 million from the exercise of stock options during the nine-month period. The Company’s income tax expense for the nine months ended September 30, 2016, does not bear the normal relationship to income before income taxes because of net operating loss carryforwards which were utilized and were partially offset by certain minimum state income taxes.

Investment Income. In the second quarter of 2016, we began to invest the MSA escrow deposits. For the nine months ended September 30, 2017 and 2016, investment income relating to investments of the MSA escrow deposits was $0.3 million and $0.6 million, respectively.

Loss on Extinguishment of Debt. For the nine months ended September 30, 2017, loss on extinguishment of debt was $6.1 million as the result of refinancing our credit facility in the first quarter of 2017. For the nine months ended September 30, 2016, loss on extinguishment of debt was $2.8 million as the result of retiring certain debt with proceeds from our IPO.

Consolidated Net Income. Due to the factors described above, net income for the nine months ended September 30, 2017 and 2016, was $16.1 million and $9.8 million, respectively.

Net Loss Attributable to Non-Controlling Interest. Net loss attributable to non-controlling interest of $0.6 million for the nine months ended September 30, 2017, is related to Vapor Shark, which was accounted for as a VIE during the second quarter.

Net Income Attributable to Turning Point Brands, Inc. Due to the factors described above, net income for the nine months ended September 30, 2017 and 2016, was $16.7 million and $9.8 million, respectively.

EBITDA and Adjusted EBITDA:

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.

In addition, our credit agreements contain financial covenants which use Adjusted EBITDA calculations.

We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider ordinary course in our evaluation of ongoing operating performance.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do, or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide a reconciliation between net income and Adjusted EBITDA for the three and nine months ended September 30, 2017 and 2016.

Three Months Ended September 30, 2017 September 30, 2016
Consolidated net income $7,374 $6,793
Add:
Interest expense 4,023 5,557
Income tax expense 3,110 (180)
Depreciation expense 421 310
Amortization expense 175 -
EBITDA $15,103 $12,480
Components of Adjusted EBITDA
LIFO adjustment (a) (641) (78)
Pension/postretirement expense (b) 84 117
Stock options, restricted stock and incentives expense (c) 226 99
Strategic initiatives (d) 219 9
New product launch costs (e) 566 1,051
Product line rationalizations (f) 314 -
Adjusted EBITDA $15,871 $13,678

(a) Represents expense related to an inventory valuation allowance for last-in, first-out ("LIFO") reporting.

(b) Represents our non-cash Pension/Postretirement expense.

(c) Represents non-cash stock options, restricted stock and incentives expense.

(d) Represents the fees incurred for the study of strategic initiatives and acquisition expenses.

(e) Represents product launch costs of our new product lines.

(f) Represents costs associated with discontinued products related to product line rationalization

Nine Months Ended September 30, 2017 September 30, 2016
Net income attributable to Turning Point Brands, Inc. $16,690 $9,826
Add:
Interest expense 13,002 20,895
Loss on extinguishment of debt 6,116 2,824
Income tax expense 3,850 642
Depreciation expense 1,192 896
Amortization expense 526 -
EBITDA $41,376 $35,083
Components of Adjusted EBITDA
LIFO adjustment (a) 246 494
Pension/postretirement expense (b) 252 353
Stock options, restricted stock and incentives expense (c) 446 145
Foreign exchange hedging (d) (90) 35
Strategic initiatives (e) 990 471
New product launch costs (f) 1,727 1,769
Product line rationalizations (g) 314 -
IPO related compensation costs (h) - 605
Adjusted EBITDA $45,261 $38,955

(a) Represents expense related to an inventory valuation allowance for last-in, first-out ("LIFO") reporting.

(b) Represents our non-cash Pension/Postretirement expense.

(c) Represents non-cash stock options, restricted stock and incentives expense.

(d) Represents non-cash gain and loss stemming from our foreign exchange hedging activities.

(e) Represents the fees incurred for the study of strategic initiatives and acquisition expenses.

(f) Represents product launch costs of our new product lines.

(g) Represents costs associated with discontinued products related to product line rationalization

(h) Represents non-recurring compensation expenses incurred with the May 2016 IPO.

Liquidity and Capital Reserves

Our principal uses for cash are working capital, debt service, capital expenditures, and acquisitions. We believe our cash flows from operations and borrowing availability under our 2017 Revolving Credit Facility (as defined herein) are adequate to satisfy our operating cash requirements for the foreseeable future.

We had working capital, which we define as current assets less current liabilities, of $36.5 million at September 30, 2017, compared to working capital of $37.3 million at December 31, 2016. This decrease is primarily the result of an increase in short-term debt maturities as a result of our February 2017 debt refinancing.

September 30, 2017 December 31, 2016
Current Assets $81,413 $78,856
Current Liabilities 44,892 41,567
Working Capital $36,521 $37,289

Cash Flows from Operating Activities

The following table sets out the principal components of our cash flows from operating activities:

Cash flows from operating activities: Nine Months Ended September 30, 2017 September 30, 2016
Consolidated net income $16,134 $9,826
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Loss on extinguishment of debt 6,116 2,824
Loss on sale of property, plant and equipment 17 -
Depreciation expense 1,192 896
Amortization of deferred financing costs 768 1,070
Amortization of original issue discount 66 591
Amortization of other intangible assets 527 -
Interest incurred but not paid on PIK Toggle Notes - 3,422
Interest incurred but not paid on 7% Senior Notes - 329
Interest paid on PIK Toggle Notes - (9,893)
Deferred income taxes 1,847 47
Stock-based compensation expense 498 145
Changes in operating assets and liabilities:
Accounts receivable (779) 546
Inventories (970) (7,405)
Other current assets 2,383 1,562
Other assets (105) (45)
Accounts payable (2,292) (531)
Accrued pension liabilities 144 196
Accrued postretirement liabilities (18) (89)
Accrued liabilities and other (5,137) (3,967)
Net cash provided by (used in) operating activities 20,391 (476)

For the nine months ended September 30, 2017, net cash provided by operating activities was $20.4 million compared to net cash used in operating activities of $0.5 million for the nine months ended September 30, 2016, an increase of $20.9 million primarily due to interest paid on PIK Toggle Notes in 2016 as a result of our IPO and improved income in 2017.

Cash Flows from Investing Activities

The following table sets out the principal components of our cash flows from investing activities:

Cash flows from investing activities: Nine Months Ended September 30, 2017 September 30, 2016
Acquisitions, net of cash acquired 268 -
Capital expenditures (1,052) (1,245)
Net cash used in investing activities (784) (1,245)

For the nine months ended September 30, 2017, net cash used in investing activities was $0.8 million compared to net cash used in investing activities of $1.2 million for the nine months ended September 30, 2016, a decrease of $0.4 million.

Cash Flows from Financing Activities

The following table sets out the principal components of our cash flows from financing activities:

Cash flows from financing activities: Nine Months Ended September 30, 2017 September 30, 2016
Proceeds from 2017 revolving credit facility 15,550 -
Proceeds from 2017 first lien term loans 145,000 -
Proceeds from 2017 second lien term loan 55,000 -
Payments of 2017 first lien term loans (2,925) -
Payments of financing costs (4,783) (200)
Payments of old revolving credit facility (15,083) (18)
Payments of first lien term loan (147,362) (3,976)
Payments of second lien term loan (60,000) (20,000)
Payments of Vapor Shark loans (1,867) -
Prepaid equity issuance costs (394) -
Payment of PIK toggle notes - (24,107)
Redemption of Intrepid options - (661)
Redemption of Intrepid warrants - (5,500)
Exercise of warrants - 4
Exercise of options 1,371 8
Redeption of options (1,740) -
Surrender of options (1,000) -
Proceeds from issuance of stock - 55,746
Distribution to non-controlling interest (4) -
Net cash provided by (used in) financing activities (18,237) 1,296

For the nine months ended September 30, 2017, net cash used in financing activities was $18.2 million compared with net cash provided by financing activities of $1.3 million for the nine months ended September 30, 2016, a decrease of $19.5 million, primarily due to proceeds from the IPO in 2016 and payments relating to our debt refinancing in 2017.

Long-Term Debt

On February 17, 2017, the Company and NATC, entered into a new $250 million secured credit facility comprised of (i) a First Lien Credit Facility with Fifth Third Bank, as administrative agent, and other lenders (the “2017 First Lien Credit Facility”) and (ii) a Second Lien Credit Facility with Prospect Capital Corporation, as administrative agent, and other lenders (the “2017 Second Lien Credit Facility,” and together with the 2017 First Lien Credit Facility, the “2017 Credit Facility”). The Company used the proceeds of the 2017 Credit Facility to repay, in full, the Company’s First Lien Term Loan, Second Lien Term Loan, and Revolving Credit Facility and to pay related fees and expenses.

The 2017 Credit Facility contains customary events of default including payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to certain other material indebtedness in excess of specified amounts, certain events of bankruptcy and insolvency, certain ERISA events, judgments in excess of specified amounts, and change in control defaults. The 2017 Credit Facility also contains certain negative covenants customary for facilities of these types including covenants that, subject to exceptions described in the 2017 Credit Facility, restrict the ability of the Company and its subsidiary guarantors: (i) to pledge assets, (ii) to incur additional indebtedness, (iii) to pay dividends, (iv) to make distributions, (v) to sell assets, and (vi) to make investments.

As of September 30, 2017, we were in compliance with the financial and restrictive covenants in our existing debt instruments. The following table provides outstanding balances under our debt instruments.

September 30, 2017 December 31, 2016
2017 Revolving Credit Facility $15,550 $-
2017 First Lien First Out Term Loan 107,250 -
2017 First Lien Second Out Term Loan 34,825 -
2017 Second Lien Term Loan 55,000 -
Notes payable - VaporBeast 2,000 2,000
Revolving Credit Facility - 15,034
First Lien Term Loan - 146,451
Second Lien Term Loan - 59,128
214,625 222,613
Less deferred financing charges (3,772) (4,388)
Less revolving credit facility (15,550) (15,034)
Less current maturities of long-term debt (7,850) (1,650)
Notes payable and long-term debt $187,453 $201,541

2017 First Lien Credit Facility

The 2017 First Lien Credit Facility consists of (i) a $50 million revolving credit facility (the “2017 Revolving Credit Facility”), (ii) a $110 million first out term loan facility (the “2017 First Out Term Loan”), and (iii) a $35 million second out term loan facility (the “2017 Second Out Term Loan”) which will be repaid in full only after repayment in full of the 2017 First Out Term Loan. The 2017 First Lien Credit Facility also includes an accordion feature allowing the Company to borrow up to an additional $40 million upon the satisfaction of certain conditions, including obtaining commitments from one or more lenders. Borrowings under the 2017 Revolving Credit Facility may be used for general corporate purposes, including acquisitions.

The 2017 First Out Term Loan and the 2017 Revolving Credit Facility have a maturity date of February 17, 2022, and the 2017 Second Out Term Loan has a maturity date of May 17, 2022. The 2017 First Out Term Loan and the 2017 Revolving Credit Facility bear interest at LIBOR plus a spread of 2.5% to 3.5% based on the Company’s senior leverage ratio. The 2017 First Out Term Loan requires quarterly payments of $1.4 million beginning June 30, 2017, increasing to $2.1 million on June 30, 2019, and increasing to $2.8 million on June 30, 2021. The 2017 Second Out Term Loan bears interest at LIBOR plus 6% (subject to a floor of 1.00%). The 2017 Second Out Term Loan has required, quarterly payments of $0.1 million beginning June 30, 2017. The 2017 First Lien Credit Facility contains certain financial covenants including a maximum senior leverage ratio of 3.75x with step-downs to 3.00x, a maximum total leverage ratio of 4.75x with step-downs to 4.00x, and a minimum fixed charge coverage ratio of 1.20x. The weighted average interest rate at September 30, 2017, on the 2017 Revolving Credit Facility was 4.3%. The weighted average interest rate at June 30, 2017, on the 2017 First Out Term Loan was 4.3%. The weighted average interest rate at September 30, 2017, on the 2017 Second Out Term Loan was 7.3%.

2017 Second Lien Credit Facility

The 2017 Second Lien Credit Facility consists of a $55 million second lien term loan (the “2017 Second Lien Term Loan”) having a maturity date of August 17, 2022. The 2017 Second Lien Term Loan bears interest at a fixed rate of 11%. The 2017 Second Lien Credit Facility contains certain financial covenants including a maximum senior leverage ratio of 4.25x with step-downs to 3.50x, a maximum total leverage ratio of 5.25x with step-downs to 4.50x, and a minimum fixed charge coverage ratio of 1.10x.

Note Payable – VaporBeast

On November 30, 2016, the Company issued a note payable to VaporBeast’s former shareholders (“VaporBeast Note.”) The VaporBeast Note is $2.0 million principal with 6% interest compounded monthly and matures on May 30, 2018.

The VaporBeast Note may be prepaid at any time without penalty and is subject to a late-payment penalty of 5% and a default rate of 13% per annum. The VaporBeast Note is subject to customary defaults including defaults for nonpayment, nonperformance, any material breach under the purchase agreement, and bankruptcy or insolvency.

First Lien Term Loan

All of NATC’s subsidiaries, as well as the Company and NATC Holding, were guarantors under the First Lien Term Loan. TPLLC and its subsidiary were not guarantors of the First Lien Term Loan. The First Lien Term Loan was secured by a first-priority lien on substantially all of the assets of the borrowers and the guarantors thereunder, including a pledge of the capital stock of NATC and its subsidiaries held by NATC Holding, NATC, or any guarantor, other than certain excluded assets. The loans designated as LIBOR loans bore interest at LIBOR then in effect (but not less than 1.25%) plus 6.50%. The loans designated as base rate loans bore interest at the (i) highest of (A) the Prime Rate, (B) the Federal Funds Rate plus 0.50%, (C) LIBOR for an interest period of one month plus 1.00%, and (D) 2.25% per year plus (ii) 5.50%. The First Lien Term Loan was paid in full with proceeds from the February 2017 refinancing.

Second Lien Term Loan

The Second Lien Term Loan was secured by a second priority security interest in the Collateral and was guaranteed by the same entities as the First Lien Term Loan.

Under the Second Lien Term Loan the loans designated as LIBOR loans bore interest at LIBOR then in effect (but not less than 1.25%) plus 10.25%. The loans designated as base rate loans bore interest at (i) the highest of (A) the Prime Rate, (B) the Federal Funds Rate plus 0.50%, (C) LIBOR for an interest period of one month plus 1.00%, and (D) 2.25% per year plus (ii) 9.25%. The Second Lien Credit Agreement was paid in full with proceeds from the February 2017 refinancing.

Revolving Credit Facility

The Revolving Credit Facility provided for aggregate commitments of up to $40 million, subject to a borrowing base which was calculated as the sum of (i) 85% of eligible accounts receivable; plus (ii) the lesser of (A) the product of 70% and the value of eligible inventory and (B) the product of (a) 85%, (b) the net recovery percentage identified in the most recent inventory appraisal, and (c) the value of eligible inventory; plus (iii) the lesser of (A) the product of 75% and the value of eligible inventory and (B) the product of (a) 85%, (b) the net recovery percentage identified in the most recent inventory appraisal, and (c) the value of the eligible finished goods inventory; minus (iv) the aggregate amount of reserves established by the administrative agent. The outstanding balance on the Revolving Credit Facility was paid in full with the proceeds from the February 2017 refinancing.

Off-balance Sheet Arrangements

As of September 30, 2017, we had no forward contracts outstanding.

As of December 31, 2016, we had forward contracts for the purchase of €4.9 million.

The effect of a hypothetical 10% change in Euro and US exchange rates applicable to our business would not have had a material impact on our consolidated financial statements.

Contractual Obligations

As of September 30, 2017, there had been no material changes outside the ordinary course of business to our contractual obligations with the exception of our long-term debt obligations due to the refinancing (see Long-Term Debt), from December 31, 2016, as reported in our 2016 Annual Report on Form 10-K filed with the SEC.

The following tables reflect the long-term debt obligations as of September 30, 2017, and December 31, 2016.

Long-Term Debt Obligations Payments due by period as of September 30, 2017 Total Less than 1 year 1-3 years 4-5 years More than 5 years
Long-term debt obligations, including interest $283,592 $47,081 $41,025 $195,486 $-
Long-Term Debt Obligations Payments due by period as of December 31, 2016 Total Less than 1 year 1-3 years 4-5 years More than 5 years
Long-term debt obligations, including interest $288,837 $39,380 $44,477 $204,980 $-

Inflation

The Company believes any effect of inflation at current levels will be minimal. Historically, we have been able to increase prices at a rate equal to, or greater than, the rate of inflation and believe we will continue to be able to do so for the foreseeable future. In addition, we have been able to maintain a relatively stable, variable cost structure for our products due, in part, to our successful procurement activities regarding our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.

Market risk

As filed, 1,168 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Foreign Currency Sensitivity

There have been no material changes in our exposure to market risk during the three months ended September 30, 2017. Please refer to our “Quantitative and Qualitative Disclosures about Market Risk” included in our 2016 Annual Report on Form 10-K filed with the SEC.

Credit Risk

There have been no material changes in our exposure to credit risk during the three months ended September 30, 2017. Please refer to our “Quantitative and Qualitative Disclosures about Market Risk” included in our 2016 Annual Report on Form 10-K filed with the SEC.

Interest Rate Sensitivity

We have exposure to interest rate volatility principally relating to interest rate changes applicable to loans under our 2017 First Lien Credit Facility. As of September 30, 2017, all debt under the 2017 First Lien Credit Facility bears interest at variable rates. We believe the effect, if any, of reasonably possible near-term changes in interest rates on our consolidated financial position, results of operations, or cash flows would not be significant. A 1% change in the interest rate would change pre-tax income by approximately $1.7 million per year.

Controls and procedures

As filed, 1,309 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We have carried out an evaluation under the supervision, and with the participation of, our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Act”)) as of September 30, 2017. Based upon the evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed by us in the reports we file or submit under the Act is: (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosures.

There have been no changes in the Company’s internal control over financial reporting during the most recent fiscal quarter which have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risk factors

As filed, 9,924 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information set forth in this report, carefully consider the factors discussed in “Risk Factors” contained in our 2016 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2016 Annual Report on Form 10-K except as set forth below.

There is uncertainty related to the federal regulation of NewGen products, cigars and pipe tobacco products. Increased regulatory compliance burdens could have a material adverse impact on our NewGen business development efforts.

Since their introduction, there has been significant uncertainty regarding whether, how and when tobacco regulations would apply to NewGen products, such as electronic cigarettes or other vaporizer products. Based on a decision in December 2010 by the U.S. Court of Appeals for the D.C. Circuit (the “Sottera decision”), the FDA is permitted to regulate electronic cigarettes containing tobacco-derived nicotine as “tobacco products” under the Tobacco Control Act.

Effective August 8, 2016, FDA’s regulatory authority under the Tobacco Control Act was extended to all remaining tobacco products, including: (i) certain NewGen products (such as electronic cigarettes, vaporizers and e-liquids) and their components or parts (such as tanks, coils and batteries); (ii) cigars and their components or parts (such as cigar tobacco); (iii) pipe tobacco, (iv) hookah products; or (v) any other tobacco product “newly deemed” by FDA. These deeming regulations apply to all products made or derived from tobacco intended for human consumption, but excluding accessories of tobacco products (such as lighters).

The deeming regulations require us to (i) register with the FDA and report product and ingredient listings; (ii) market newly deemed products only after FDA review and approval; (iii) only make direct and implied claims of reduced risk if the FDA approves after finding that scientific evidence supports the claim and that marketing the product will benefit public health as a whole; (iv) refrain from distributing free samples; (v) implement minimum age and identification restrictions to prevent sales to individuals under age 18; (vi) develop an approved warning plan and include prescribed health warnings on packaging and advertisements; and (vii) refrain from selling the products in vending machines, unless the machine is located in a facility that never admits youth. Newly-deemed tobacco products are also subject to the other requirements of the Tobacco Control Act, such as that they not be adulterated or misbranded. The FDA could in the future promulgate good manufacturing practice regulations for these and our other products, which could have a material adverse impact on our ability and the cost to manufacture our products.

Marketing authorizations will be necessary in order for us to continue our distribution of NewGen and cigar and pipe tobacco products, with the exception of our “grandfathered” products (products in commerce as of February 15, 2007) which are already authorized. On July 28, 2017, the FDA announced a new direction in regulating tobacco products, including the newly “deemed” markets such as cigars and vapor products. The FDA stated it intends to begin several new rulemaking processes, some of which will outline foundational rules governing the premarket application process for the deemed products, including Substantial Equivalence Applications and Premarket Tobacco Applications. Accordingly, the original filing deadlines for newly “deemed” products on the market as of August 8, 2016, have been postponed until August 8, 2021, for “combustible” products (e.g., cigar and pipe) and August 8, 2022, for “non-combustible” products (e.g., vapor products). The FDA did not relax any of the requirements for Premarket Tobacco Applications, which could result in the cost of the premarket process exceeding the level of sales and profit that many products would justify. We intend to evaluate our products and timely file for the appropriate authorizations to allow us to sell our products in the U.S. We have no assurances that the outcome of such processes will result in our products receiving marketing authorizations from the FDA. We also have certain previously-regulated tobacco products which remain subject to “provisional” substantial equivalence filings made on March 22, 2011. If the FDA establishes regulatory processes that we are unable or unwilling to comply with, our business, results of operations, financial condition and prospects could be adversely affected.

The anticipated costs of complying with future FDA regulations will be dependent on the rules issued by the FDA, the timing and clarity of any new rules or guidance documents accompanying these rules, the reliability and simplicity (or complexity) of the electronic systems utilized by FDA for information and reports to be submitted, and the details required by FDA for such information and reports with respect to each regulated product (which have yet to be issued by FDA). Failure to comply with existing or new FDA regulatory requirements could result in significant financial penalties and could have a material adverse effect on our business, results of operations, financial condition and ability to market and sell our products. Compliance and related costs could be substantial and could significantly increase the costs of operating in our NewGen and cigar and pipe tobacco product markets. Substantial compliance and related costs could also have a material adverse impact on the timing and realization of anticipated benefits from recent acquisitions and potential future NewGen market penetration.

In addition, failure to comply with the Tobacco Control Act and with FDA regulatory requirements could result in litigation, criminal convictions or significant financial penalties and could impair our ability to market and sell our electronic and vaporizer products. At present, we are not able to predict whether the Tobacco Control Act will impact our products to a greater degree than competitors in the industry, thus affecting our competitive position.

Furthermore, neither the Prevent All Cigarette Trafficking Act nor the Federal Cigarette Labeling and Advertising Act currently apply to NewGen products. There may, in the future, also be increased regulation of additives in smokeless products and internet sales of NewGen products. The application of either or both of these federal laws, and of any new laws or regulations which may be adopted in the future, to NewGen products or such additives could result in additional expenses and require us to change our advertising and labeling, and methods of marketing and distribution of our products, any of which could have a material adverse effect on our business, results of operations and financial condition.

Our principal stockholders will be able to exert significant influence over matters submitted to our stockholders and may take certain actions to prevent takeovers.

Standard General L.P., and funds managed by it (together with the funds it manages, “Standard General”), beneficially owns approximately 52.9% of our common stock. The existence of these and other significant stockholders may have the effect of deterring hostile takeovers, delaying or preventing changes in control or changes in management, or limiting the ability of our other stockholders to approve transactions they may deem to be in the best interests of our company. Our significant stockholders will be able to exert significant influence over the decision, if any, to authorize additional capital stock, which, if issued, could have a significant dilutive effect on holders of common stock.

On June 1, 2017, Standard General and our Non-Executive Chairman Thomas Helms, in the aggregate, contributed approximately 52.2% of our issued and outstanding stock in exchange for newly issued shares of Class A Common Stock of Standard Diversified Opportunities, Inc. (‘SDOI”). Following the exchange, SDOI owns approximately 52.2% of our stock. Standard General own approximately 94.0% of SDOI’s issued and outstanding Class A Common Stock and 88.7% of SDOI’s issued and outstanding Class B Common Stock

Our certificate of incorporation states the doctrine of “corporate opportunity” will not apply against Standard General or SDOI in a manner that would prohibit them from investing in competing businesses or doing business with our customers. To the extent they invest in such other businesses, Standard General or SDOI may have differing interests than our other stockholders. In addition, Standard General and SDOI are permitted to engage in business activities or invest in, or acquire, businesses which may compete with or do business with any competitors of ours.

Furthermore, Standard General is in the business of managing investment funds. Either Standard General or SDOI may pursue acquisition opportunities which may be complementary to our business, and, as a result, such acquisition opportunities may not be available to us.

Our status as a "controlled company" could make our common stock less attractive to some investors or otherwise harm our stock price.

Because we qualify as a "controlled company" under the corporate governance rules for NYSE-listed companies we are not required to have, and could elect in the future not to have, a majority of our board of directors be independent, a compensation committee, or an independent nominating function. Accordingly, should the interests of our controlling stockholder differ from those of other stockholders, the other stockholders may not have the same protections afforded to stockholders of companies subject to all of the corporate governance rules for NYSE-listed companies. Our status as a controlled company could make our common stock less attractive to some investors or otherwise harm our stock price.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Gross profit3 months2017-07-01 to 2017-09-30$32.9mus-gaap:GrossProfit
Gross profit9 months2017-01-01 to 2017-09-30$92.6mus-gaap:GrossProfit
Selling, general and administrative3 months2017-07-01 to 2017-09-30$18.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2017-01-01 to 2017-09-30$53.8mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-07-01 to 2017-09-30$14.4mus-gaap:OperatingIncomeLoss
Operating income9 months2017-01-01 to 2017-09-30$38.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-07-01 to 2017-09-30$4.0mus-gaap:InterestExpense
Interest expense9 months2017-01-01 to 2017-09-30$13.0mus-gaap:InterestExpense
Income tax3 months2017-07-01 to 2017-09-30$3.1mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2017-01-01 to 2017-09-30$3.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-07-01 to 2017-09-30$7.4mus-gaap:NetIncomeLoss
Net income9 months2017-01-01 to 2017-09-30$16.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-07-01 to 2017-09-30$0.38us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2017-01-01 to 2017-09-30$0.86us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-07-01 to 2017-09-30$0.39us-gaap:EarningsPerShareBasic
Basic EPS9 months2017-01-01 to 2017-09-30$0.88us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-07-01 to 2017-09-3019,589,424 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2017-01-01 to 2017-09-3019,503,130 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2017-01-01 to 2017-09-30$20.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2017-07-01 to 2017-09-30$485.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Capital expenditure9 months2017-01-01 to 2017-09-30$1.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-09-30$4.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-09-30$81.4mus-gaap:AssetsCurrent
Total assetsAt period end2017-09-30$287.4mus-gaap:Assets
Current liabilitiesAt period end2017-09-30$44.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-09-30$237.7mus-gaap:Liabilities
Long-term debtAt period end2017-09-30$187.5mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2017-09-30$7.8mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2017-09-30$49.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001140361-17-041819. Last ingested by Listed: Nov 10, 2026, 02:39 ET. Listed shows no prices and gives no investment advice.